Abstract 1865P
Background
This study aimed to determine how the chemotherapy process can lead to a change in self-esteem in elderly patients with early-stage breast cancer according to personality type.
Methods
The research was completed as a pilot study between 2019-2022. Female patients aged 65 and over who were planned for adjuvant treatment were included in the study. Personality type and self-esteem were determined in all patients before and after adjuvant chemotherapy. Bortner Rating Scale was used to determine personality type, and Rosenberg Self-Esteem Scale was used to determine self-confidence. Paired t-test was performed for recurrent variables in pre-treatment and post-treatment measures. Multivariate logistic (binary) regression analysis was performed to determine the independent factors affecting low self-esteem from the study variables with the model created as a result of correlation and univariate analysis. Statistical analysis was performed using the SPSS v19 program and a p value of <0.05 was considered statistically significant.
Results
A total of 69 Her2-negative elderly female patients were included in this pilot study. The mean age of the patients was 68 years (65-72). 54% had radical mastectomy. 69% received paclitaxel for 12 weeks, 21% received 6x DC, and 10% received 3x CEF followed by 3x docetaxel for adjuvant setting. 56% of them had personality type A. Before treatment, 62% had high self-esteem and this was significantly higher in type A personality than in type B (84% vs 48%, respectively; p=0.037). While the rate of high self-esteem decreased in type A personality after treatment (p=0.009), there was no change in type B personality (p=0.379). It was determined that type A personality structure was independent affecting low self-esteem after treatment (OR 5.37 95%CI 1.489-9.396; p=0.006).
Conclusions
In this study, it was concluded that elderly women with type A personality structure may be more sensitive and may have low self-esteem after the treatment is completed. It was concluded that the personality type should be guided by the patient's treatment compliance, need for psychosocial support, and coping methods after the completion of the treatment, supported by the physician.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Ethics committee approval could not be obtained because it was a pilot study. In the follow-up research, the results of the pilot study will be declared and consent will be obtained.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
1614P - Integrated palliative care for patients referred for Chimeric Antigen Receptor T-cell (CAR-T) therapy: A service evaluation
Presenter: Rebekah Williams
Session: Poster session 05
1615P - Investigation of status of lung cancer palliative care management and concept and practice in Chinese medical providers
Presenter: Liling Ma
Session: Poster session 05
1845P - Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
Presenter: Paul Matte
Session: Poster session 05
1846P - The impact of newly diagnosed early breast cancer on distress, perception of health and psychologic resilience
Presenter: Anuska Budisavljevic
Session: Poster session 05
1847P - Monitoring of psychological state and quality of life during Simonton-training for oncologic patients
Presenter: Petra Harasztosi
Session: Poster session 05
1849P - Use of antipsychotic drugs during radiotherapy in adult cancer patients in Korea: The nationwide retrospective cohort study based on the health insurance review and assessment service database
Presenter: JIN HWA CHOI
Session: Poster session 05
1851P - Psychological well-being of patients with colorectal cancer during the third wave of the COVID-19 pandemic: Results from cohort II of the PICO-SM study
Presenter: Konstantinos Kamposioras
Session: Poster session 05
1852P - Mental health among Tunisian oncologists
Presenter: nefzi issaad
Session: Poster session 05
1853P - Effect of logotherapy on anxiety in patients with cancer: A systematic review and meta-analysis
Presenter: Douglas Barroso
Session: Poster session 05
1854P - The role of “1 minute” time perception in evaluating depression and anxiety in cancer patients receiving chemotherapy
Presenter: Sait Kitaplı
Session: Poster session 05